GRAFAPEX

NDC 59137-335 · Medexus Pharma, Inc.

Generic nametreosulfan

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)TREOSULFAN

Strength1000 mg/g

Marketing categoryNDA

Packages

59137-335-01 — 1 VIAL in 1 CARTON (59137-335-01) / 1 g in 1 VIAL

J0614 — Injection, treosulfan, 50 mg Medicare Part B payment limit (ASP + 6%): $32.33

FDA lists these products with the same active ingredient.

59137-365 — treosulfan

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.